PT Pyridam Farma Tbk (ISX:PYFA) Cash And Cash Equivalents : Rp351,857 Mil (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is PT Pyridam Farma Tbk Cash And Cash Equivalents?

PT Pyridam Farma Tbk's quarterly cash and cash equivalents declined from Jun. 2024 (Rp649,760.00 Mil) to Sep. 2024 (Rp505,423.00 Mil) but then stayed the same from Sep. 2024 (Rp505,423.00 Mil) to Dec. 2024 (Rp351,857.26 Mil).

PT Pyridam Farma Tbk's annual cash and cash equivalents declined from Dec. 2022 (Rp136,579.60 Mil) to Dec. 2023 (Rp89,969.78 Mil) but then increased from Dec. 2023 (Rp89,969.78 Mil) to Dec. 2024 (Rp351,857.26 Mil).

PT Pyridam Farma Tbk Cash And Cash Equivalents Historical Data

The historical data trend for PT Pyridam Farma Tbk's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Pyridam Farma Tbk Cash And Cash Equivalents Chart

PT Pyridam Farma Tbk Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash And Cash Equivalents

Get a 7-Day Free Trial

9,635.90

47,733.24

136,579.60

89,969.78

351,857.26

PT Pyridam Farma Tbk Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash And Cash Equivalents	Get a 7-Day Free Trial															89,969.78	453,647.72	649,760.00	505,423.00	351,857.26

PT Pyridam Farma Tbk Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

PT Pyridam Farma Tbk (ISX:PYFA) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

PT Pyridam Farma Tbk Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of PT Pyridam Farma Tbk's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Pyridam Farma Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Pyridam Farma Tbk (ISX:PYFA) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jl. Gen. Sudirman No. Kav. 21, Sinarmas MSIG Tower Lt. 12, RT.10/RW.1, Kuningan, Karet, Setiabudi District, South Jakarta City, Jakarta, IDN, 12920

Website

https://www.pyfa.co.id

PT Pyridam Farma Tbk is engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through two segments namely Pharmaceutical Products and Toll Manufacturing Services; and Medical Device Products. The company derives maximum revenue from Pharmaceutical Products and Toll Manufacturing Services. The company's products include consumer health, Derma, prescription, and biomedilab.

PT Pyridam Farma Tbk Headlines

No Headlines